Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Antitumorigenic Effect of Dietary Natural Compounds via Lipid Metabolism Modulation in ApcMin/+ Mice

MARIA NOTARNICOLA, VALERIA TUTINO, ANGELA TAFARO, FRANCESCA AMATULLI and MARIA GABRIELLA CARUSO
Anticancer Research September 2013, 33 (9) 3739-3744;
MARIA NOTARNICOLA
1Laboratory of Nutritional Biochemistry, National Institute for Digestive Diseases, Castellana Grotte, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VALERIA TUTINO
1Laboratory of Nutritional Biochemistry, National Institute for Digestive Diseases, Castellana Grotte, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANGELA TAFARO
2Animal Facility, National Institute for Digestive Diseases, Castellana Grotte, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANCESCA AMATULLI
1Laboratory of Nutritional Biochemistry, National Institute for Digestive Diseases, Castellana Grotte, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA GABRIELLA CARUSO
1Laboratory of Nutritional Biochemistry, National Institute for Digestive Diseases, Castellana Grotte, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gabriella.caruso{at}irccsdebellis.it
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Aim: The aim of the present study was to evaluate the effects of a diet supplementation with either olive oil, or n-3 or n-6-polyunsaturatedFatty acids (PUFAs) on tumour development and gene expression for lipogenic enzymes in ApcMin/+ mice. Materials and Methods: In the control group, the mice received a standard diet, the OO group was fed on a diet with 12% olive oil, the OM-3 group with 12% salmon fish rich in n-3 PUFAs, the OM-6 group with 12% oenothera oil rich in n-6 PUFAs. Gene expression of lipogenic enzymes was evaluated by real-time reverse transcription polymerase chain reaction. Results: All mice in the treated groups presented a reduction in total intestinal polyp number and load, which was particularly marked in the OM-3 group. Treated mice showed an induction of low density lipoprotein receptor gene expression and a significant reduction of expression of lipogenic gene. Conclusion: Our data provide new insights into the mechanism of cell growth inhibition and apoptotic regulation by dietary olive oil and PUFAs in ApcMin/+ mice.

  • Olive oil
  • polyunsaturated fatty acids (PUFAs)
  • colorectal cancer
  • lipid metabolism
  • gene expression

Lipid metabolism in cancer cells is regulated by the common oncogenic signaling pathways and is believed to be important for the initiation and progression of tumors (1, 2). Alterations in the mevalonate pathway, the main metabolic way used by proliferating cells to gain lipids for cell membrane synthesis, are common in neoplasia (3). The activity of 3-hydroxy-3-methyl-glutaryl CoA reductase (HMGCoAR) is up-regulated by several fold in colonic tumors and does not respond to the inhibitory feedback induced by cholesterol (4).

Cancer cells seem to require an increased concentration of cholesterol and cholesterol precursors and this requirement may be fulfilled by increased HMGCoAR activity. In our previous study, HMGCoAR activity was found to be enhanced in human colorectal cancer that did not express low density lipoprotein receptor (LDL-R), indicating that LDL-R absence, which deprives colonic neoplastic cells of exogenous sterols, is overcome by an increase in endogenous cholesterol synthesis (5).

These observations suggest that the LDL-R has a role in cell growth and tumorigenesis. In this connection, interest has been attributed on factors regulating LDL-R expression. Previously, we demonstrated the efficacy of eicosapentaenoic acid (EPA), belonging to the of omega-3 family polyunsaturated fatty acids (PUFAs), and lovastatin, a potent inhibitor of HMGCoAR, in gene expression regulation of HMGCoA reductase and LDL-R in the HepG2 cell line (6).

Several studies have revealed that PUFAs can regulate the expression of genes involved in several metabolic pathways (7, 8). Feeding with fish oil, rich in n-3 PUFAs, drastically reduced mRNA levels of genes for lipogenic enzymes in rodent liver (9). PUFAs may control cholesterogenic gene expression through their effects on (SREBP)-dependent regulation (7). SREBP-responsive genes include those coding for HMGCoAR and for intermediates in cholesterol synthesis, such as farnesyl pirophosphate synthase (FPPS). PUFAs reduced mRNA levels of lipogenic enzymes in rat hepatoma cells and mouse liver, in correlation with their effects on HMGCoAR (9).

In addition, dietary n-3-PUFAs can reduce tumor load in mice with an (APC) defect (10). There is also clinical evidence that these fatty acids have specific effects on disease prevention, reducing rectal polyp number and size in patients with familial adenomatous polyposis (FAP) (11).

A recent clinical study demonstrated that adherence to a Mediterranean diet reduces the risk of colorectal cancer (12). Another study shows that a Mediterranean diet, supplemented with extra-virgin olive oil or nuts, reduces the incidence of major cardiovascular events (13). The healthy effects of olive oil can be attributed not only to the higher ratio of unsaturated to saturated fatty acids, but also to the antioxidant property of its phenolic compounds, such as oleuropein (OL) and hydroxytyrosol (HT) (14-16). In fact, we have previously demonstrated that HT and OL, the main polyphenols contained in olive oil, have antiproliferative effects and induce apoptosis of human colorectal cancer cells by suppressing fatty acid synthase activity (17). Moreover, we have recently shown that HT causes an evident antiproliferative effect in a dose- and time-dependent manner on two human hepatoma cell lines, HepG2 and Hep3B. This antiproliferative effect was mediated by down regulation of lipogenic enzymes, activation of the cell antioxidant system, and reduction of cellular (IL-6) levels (18).

Taking this background into account, the present study was designed to evaluate the effects of a diet supplementation with either olive oil, or n-3-PUFAs, or n-6-PUFAs in the ApcMin/+ mouse model, an experimental model that closely mimics the mechanisms of APC gene inactivation observed in patients with FAP and in most sporadic colon adenomas. Moreover, the study explores the molecular mechanisms and gene modulation involved in these dietary effects.

Materials and Methods

Animals and experimental study design. Five-week-old C57BL/6J mice with an heterozygote mutation for the Apc gene (ApcMin/+) and wild-type mice were obtained from Charles River (Calco, CO, Italy). Mice were maintained in temperature, air- and light-controlled conditions and received food and water ad libitum. Animals did not receive any surgical or hormonal manipulation. All animals received care in compliance with the “Guide for the Care and Use of Laboratory Animals”. The procedures related to animal use have been communicated to the Italian Ministry of Health and approved (art. 7 DL 116/92, RC2011).

ApcMin/+ mice were randomly divided into four groups fed for 10 weeks with isocaloric diets in which the fat source in each was different: Control group, n=10 animals received a standard diet (12.5% protein, 12% soya bean oil, 3% fiber); OO group, n=10 animals received a standard diet in which soya bean oil was substituted with olive oil (12.5% protein, 12% olive oil, 3% fiber); OM-3 group, n=10 animals fed a diet in which soya bean oil was substituted with 12% of salmon fish rich in n-3 PUFAs; OM-6 group, n=10 animals fed a diet in which soya bean oil was substituted with 12% of oenothera oil rich in n-6 PUFAs. To control laboratory conditions, wild-type syngenic mice (n=5) were fed the standard diet for 10 weeks and killed for molecular analyses as described hereafter.

All diets were provided in pellet form (Mucedola Srl, Settimo Milanese, Italy) and immediately divided into daily aliquots and stored at −80°C to prevent PUFA oxidation. Mice were provided with fresh food daily, and body weights were recorded weekly.

After 10 weeks of dietary treatment, animals were killed by cervical dislocation and the entire intestinal tract was immediately removed and washed with cold phosphate-buffered saline (PBS). The small bowel was divided into three segments: proximal, medial and distal intestine, and all segments of the small intestine and colon were cut along the mesenteric insertion, placed on a paper strip at 0-4°C and analyzed by a stereomicroscope in order to evaluate the number, location and size of polyps, calculated considering them as hemispheres (1/2×3/4 π r3). Fresh tissue samples of intestine and colon were collected and stored at −80°C until assayed.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Sequences of amplification primers.

Lipogenic gene expression analysis and apoptotic death assay. To study the effects of the diets on gene expression of lipogenic enzymes and of apoptosis in the intestinal distal tract from treated mice, the mRNA levels of LDL-R, FPPS and HMGCoAR genes, as well as the levels of (Bax) and (Bcl2) were assessed by real-time (RT-PCR). The reactions were performed using a master mix with SYBR Green (iQ SYBR Green Supermix, Bio-Rad, Milan, Italy) and sense and antisense primers for the target genes and the β-actin gene (Table I). Real-time PCR was carried out in an CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories, Inc.) using the following protocol: 45 cycles at 95°C for 3 min, 95°C for 10 s, 55°C for 30 s followed by a melting curve step at 65-95°C at a heating rate of 0.5°C per cycle for 80 cycles. The PCR products were quantified by external calibration curves, one for each tested gene, obtained with serial dilutions of known copy number of molecules (102-107 molecules). All expression data were normalized by dividing the target amount by the amount of β-actin used as internal control for each sample. The specificity of PCR products were confirmed by gel electrophoresis.

Statistical analysis. The significance of the differences among experimental groups was evaluated with one-way analysis of variance (ANOVA) and Tukey's multiple comparison test. Differences were considered significant at a 5% probability level. The correlation analysis between LDL-R and HMGCoAR mRNA levels was performed by nonparametric correlation test (Spearman correlation).

Results

The body weights of ApcMin/+ mice and wild-type mice did not differ significantly during the study and the final body weights were 22.5±3.1 g and 25±1.5 g, respectively. Average daily food intake of ApcMin/+ mice and wild-type mice did not differ significantly.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A: Number of polyps in the whole intestinal tract from ApcMin/+ mice treated groups: ST, Standard diet; OO, standard diet supplemented with olive oil; OM-3, standard diet supplemented with n-3 PUFAs; OM-6, standard diet supplemented with n-6-PUFAs. Data are expressed as the mean±SE. *p<0.05 vs. ST group (one-way analysis of variance and Tukey's multiple comparison test). §p<0.05 vs. OO and OM-6 groups (Tukey's multiple comparison test). B: Polyp volume (mm3) calculated for all polyps in the whole intestinal tract from mice. Data are expressed as the mean±SE. *p<0.05 vs. ST group (one-way analysis of variance and Tukey's multiple comparison test).

After 10 weeks of dietary treatment, none of the animals fed with experimental diets showed any observable toxicity or any gross changes attributable to liver, kidney or lung toxicity.

Figure 1A shows that the diet enriched with n-3 PUFAs induced a statistically significant reduction in total polyp number along the entire intestinal tract compared with the mice fed the standard diet and with mice treated with olive oil and n-6-PUFAs. As far as polyp volume is concerned, all the dietary-treated groups presented a significant reduction, this being particularly marked in the OM-3 group when compared with mice fed the standard diet (Figure 1B).

Gene expression. Figure 2 shows LDL-R, FPPS and HMGCoAR mRNA levels in the distal intestinal mucosa of wild-type mice. The levels of gene expression detected in wild-type mice are comparable to those detected in ApcMin/+ mice fed on the standard diet.

All dietary-treated groups presented an induction of LDL-R gene expression when compared with ApcMin/+ mice fed on the standard diet. The up-regulation was significantly evident in ApcMin/+ mice treated with n-3-PUFAs (Figure 3). All dietary treatments caused a reduction of FPPS gene expression levels. In particular, diets containing olive oil, as well as n-6 PUFAs had a significant effect on the reduction of FPPS mRNA (p<0.05 by Tukey's multiple comparison test) (Figure 3). For HMGCoAR expression, olive oil treatment elicited a statistically significant reduction of mRNA levels for these enzymes when compared to the group with standard diet (p<0.05 by Tukey's multiple comparison test).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

LDL-R, FPPS and HMGCoAR mRNA levels (mean±SE) in distal intestinal mucosa of wild-type mice. Data are expressed as no. molecules mRNA target gene/no molecules mRNA β-actin.

In mice treated with a diet enriched with n-3 PUFAs, a strong negative correlation was observed between HMGCoAR and LDL-R gene expression (Spearman r=−0.9, p-value=0.08) (Figure 4).

To examine the effects of dietary treatment on apoptosis, Bax and Bcl2 gene expression were evaluated in intestinal distal tract samples. We observed a striking significant increase of Bax mRNA levels, especially in animals receiving n-3 PUFA, associated with a modest decrease of Bcl2 mRNA levels, compared to the control group (Figure 5).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

LDL-R, FPPS and HMGCoAR mRNA levels (mean±SE) in distal intestinal mucosa from ApcMin/+ mice treated groups: ST, Standard diet; OO, standard diet supplemented with olive oil; OM-3, standard diet supplemented with n-3 PUFAs; OM-6, standard diet supplemented with n-6 PUFAs. Data are expressed as no. molecules mRNA target gene/no. molecules mRNA β-actin. *p<0.05 vs. ST group (one-way analysis of variance and Tukey's multiple comparison test).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Spearman correlation between HMGCoAR and LDL-R mRNA levels in ApcMin/+ mice from OM-3 group fed with standard diet supplemented with n-3 PUFAs (Spearman r=−0.9, p-value=0.08).

Discussion

Our data confirm a role for increased gene expression of LDL-R and for reduced gene expression of FPPS and HMGCoAR as a partial explanation for the antitumor effect of natural dietary treatments on ApcMin/+ mice. Moreover, it appears that enhanced apoptosis, after n-3-PUFA administration, may be responsible for preventing increased tumor number and load in these mice.

An important feature of colon malignant transformation of the colon is the loss of the cholesterol feedback inhibition mechanism that regulates cholesterol synthesis. The down-regulation of the LDL-R expression in neoplastic cells makes tumors dependent on endogenous cholesterol synthesis for their proliferation, resulting in an increase of HMGCoA reductase activity in the cells and consequently in an increase of cholesterol and mevalonate-derived metabolites, such as isoprenoid compounds.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Bax and Bcl2 mRNA levels (mean±SE) in distal intestinal mucosa from ApcMin/+ mice for four groups of treatment (ST, standard diet; OO, standard diet supplemented with olive oil; OM-3, standard diet supplemented with n-3 PUFAs; OM-6, standard diet supplemented with n-6 PUFAs). Data are expressed as no. molecules mRNA target gene/no. molecules mRNA β-actin. *p<0.05 vs. ST group (one-way analysis of variance and Tukey's multiple comparison test).

Several studies have elucidated the role of isoprenoid and the cholesterol biosynthetic pathway in colonic tumorigenesis (19-21). Inhibitors of the enzymes of the mevalonate pathway are considered to be potential antitumor agents because of their ability to inhibit cellular growth and proliferation (22). Our previous study demonstrated that exposure of DLD-1 cells to a selective inhibitor of FPPS, promoted the apoptotic process, reinforcing the role of isoprenoids in the regulation of cellular metabolic processes (23).

It is well-established that some key dietary components are able to influence cellular dynamics in the colonic epithelium (24). This is noteworthy because the balance between apoptosis and proliferation is critical to the maintenance of steady-state cell populations in the intestine. The promotion of apoptosis is an important aspect of chemoprevention.

In literature there is unequivocal morphological evidence that PUFAs induce apoptosis in vitro (24-26). The mechanism of induction of apoptosis by PUFAs could involve the disruption of membrane fluidity or the involvement of any of the multiple products of PUFA metabolism directly or by releasing a second messenger. In fact, the antitumor effect of dietary n-3-PUFAs detected in this study seems to be associated with enhanced apoptosis and the regulation of lipid metabolism.

For olive oil, the same mechanism can be also hypothesized. It is generally accepted that phenolic compounds of olive oil may exert their cancer-preventive activity by interfering with proliferation and apoptosis of cancer cells (27). Several human and animal studies have shown that olive oil phenols are bioavailable and they are absorbed in the small intestine (28-30). The antiproliferative and proapoptotic effects of olive oil detected in this study are mediated by lipid metabolism modulation.

All natural compounds studied seem to be able to elicit their effects through the down-regulation of HMGCoAR and FPPS gene expression, associated with the induction of LDL-R mRNA, even if this induction is statistically significant only for mice treated with n-3 PUFA.

LDL-R has important implications in the control of cell survival and cell death, having an inhibitory effect on tumor cell growth (5, 6). Moreover, in mice treated with n-3 PUFA, LDL-R and HMGCoAR gene expression appear to be strongly correlated, underlying the importance of dietary treatment in controlling LDL-R up-regulation and HMGCoAR down-regulation.

In conclusion, our data provide new insights into the mechanism of cell growth inhibition and apoptotic regulation by dietary olive oil and PUFAs. These effects associated with lipogenic enzyme expression modifications strongly suggest a causative role for these enzymes in regulating tumor cell growth; therefore, the use of these natural compounds in an anticancer therapeutic strategy should be encouraged.

Acknowledgements

The Authors thank Mr. Vito Spilotro for his excellent technical assistance.

  • Received June 18, 2013.
  • Revision received June 28, 2013.
  • Accepted July 1, 2013.
  • Copyright© 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Zhang F,
    2. Du G
    : Dysregulated lipid metabolism in cancer. World J Biol Chem 3(8): 167-174, 2012.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Cairns RA,
    2. Harris IS,
    3. Mak TW
    : Regulation of cancer cell metabolism. Nat Rev Cancer 11: 85-95, 2011.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Menendez JA,
    2. Lupu R
    : Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7: 763-777, 2007.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Notarnicola M,
    2. Messa C,
    3. Pricci M,
    4. Guerra V,
    5. Altomare DF,
    6. Montemurro S,
    7. Caruso MG
    : Up-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in left-sided human colon cancer. Anticancer Res 24: 3837-3842, 2004.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Caruso MG,
    2. Notarnicola M,
    3. Santillo MR,
    4. Cavallini A,
    5. Di Leo A
    : Enhanced 3-hydroxy-3-methyl-glutaryl coenzyme A reductase activity in human colorectal cancer not expressing low- density lipoprotein receptor. Anticancer Res 19: 451-454, 1999.
    OpenUrlPubMed
  6. ↵
    1. Notarnicola M,
    2. Messa C,
    3. Refolo MG,
    4. Tutino V,
    5. Miccolis A,
    6. Caruso MG
    : Synergic effect of Eicosanpetaenoic acid and lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells. Lipids Health Dis 9: 135, 2010.
    OpenUrlPubMed
  7. ↵
    1. Le Jossic-Corcos C,
    2. Gonthier C,
    3. Zaghini I,
    4. Logette E,
    5. Shechter I,
    6. Bournot P
    : Hepatic farnesyl diphosphate synthase expression is suppressed by polyunsaturated fatty acids. Biochem J 385: 787-794, 2005.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Risè P,
    2. Marangoni F,
    3. Galli C
    : Regulation of PUFA metabolism: pharmacological and toxicological aspects. Prost Leuk Essen Fatty Acids 67: 85-89, 2002.
    OpenUrl
  9. ↵
    1. Choi YS,
    2. Goto S,
    3. Ikeda I,
    4. Sugano M
    : Effect of dietary n-3 polyunsaturated fatty acids on cholesterol synthesis and degradation in rats of different ages. Lipids 24: 45-50, 1989.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Fini L,
    2. Piazzi G,
    3. Ceccarelli C,
    4. Daoud Y,
    5. Belluzzi A,
    6. Munarini A,
    7. Graziani G,
    8. Fogliano V,
    9. Selgrad M,
    10. Garcia M,
    11. Gasbarrini A,
    12. Genta RM,
    13. Boland CR,
    14. Ricciardiello L
    : Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in ApcMIN/+ mice. Clin Cancer Res 16(23): 5703-5711, 2010.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. West NJ,
    2. Clark SK,
    3. Philips RKS,
    4. Hutchinson JM,
    5. Leicester RJ,
    6. Belluzzi A,
    7. Hull MA
    : Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut 59: 918-925, 2010.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Agnoli C,
    2. Grioni S,
    3. Sieri S,
    4. Palli D,
    5. Masala G,
    6. Sacerdote C,
    7. Vineis P,
    8. Tumino R,
    9. Giurdanella MC,
    10. Pala V,
    11. Berrino F,
    12. Mattiello A,
    13. Panico S,
    14. Krogh V
    : Italian Mediterranean Index and risk of colorectal cancer in the Italian section of the EPIC cohort. Int J Cancer 132: 1404-1411, 2013.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Estruch R,
    2. Ros E,
    3. Salas-Salvadò J,
    4. Covas MI,
    5. Corella D,
    6. Arós F,
    7. Gómez-Gracia E,
    8. Ruiz-Gutiérrez V,
    9. Fiol M,
    10. Lapetra J,
    11. Lamuela-Raventos RM,
    12. Serra-Majem L,
    13. Pintó X,
    14. Basora J,
    15. Muñoz MA,
    16. Sorlí JV,
    17. Martínez JA,
    18. Martínez-González MA,
    19. PREDIMED Study Investigators
    : Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368: 1279-1290, 2013.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Owen RW,
    2. Giocosa A,
    3. Hull WE,
    4. Haubner R,
    5. Wurtele G,
    6. Spiegelhalder B,
    7. Bartsch H
    : The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. Eur J Cancer 36: 1235-1247, 2000.
    OpenUrlCrossRefPubMed
    1. Owen RW,
    2. Giacosa A,
    3. Hull WE,
    4. Haubner R,
    5. Wurtele G,
    6. Spiegelhalder B,
    7. Bartsch H
    : Olive-oil consumption and health: The possible role of antioxidants. Lancet Oncol 1: 107-112, 2000.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Perona JS,
    2. Cabello-Moruno R,
    3. Ruiz-Gutierrez V
    : The role of virgin olive oil components in the modulation of endothelial function. J Nutr Biochem 17: 429-445, 2006.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Notarnicola M,
    2. Pisanti S,
    3. Tutino V,
    4. Bocale D,
    5. Rotelli MT,
    6. Gentile A,
    7. Memeo V,
    8. Bifulco M,
    9. Perri E,
    10. Caruso MG
    : Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. Genes Nutr 6: 63-69, 2011.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Tutino V,
    2. Caruso MG,
    3. Messa C,
    4. Perri E,
    5. Notarnicola M
    : Antiproliferative, antioxidant and anti-inflammatory effects of hydroxytyrosol on human hepatoma HepG2 and Hep3B cell lines. Anticancer Res 32(12): 5371-5377, 2012.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Rao KN
    : The significance of cholesterol biosynthetic pathway in cell growth and carcinogenesis. Anticancer Res 15: 309-314, 1995.
    OpenUrlPubMed
    1. Caruso MG,
    2. Osella AR,
    3. Notarnicola M,
    4. Berloco P,
    5. Leo S,
    6. Bonfiglio C,
    7. Di Leo A
    : Prognostic value of LDL-receptor expression in colorectal carcinoma. Oncol Rep 5: 927-930, 1998.
    OpenUrlPubMed
  19. ↵
    1. Holstein SA,
    2. Wohlford-Lenane CL,
    3. Hohl RJ
    : Isoprenoids influence expression of Ras and Ras-related proteins. Biochemistry 41: 13698-13704, 2002.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Amin D,
    2. Cornell SA,
    3. Gustafson SK,
    4. Needle SJ,
    5. Ullrich JW,
    6. Bilder GE,
    7. Perrone MH
    : Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis. J Lipid Res 33: 1657-1663, 1992.
    OpenUrlAbstract
  21. ↵
    1. Notarnicola M,
    2. Messa C,
    3. Cavallini A,
    4. Bifulco M,
    5. Tecce MF,
    6. Eletto D,
    7. Di Leo A,
    8. Montemurro S,
    9. Laezza C,
    10. Caruso MG
    : Higher farnesyl diphosphate synthase activity in human colorectal cancer: Inhibition of cellular apoptosis. Oncology 67: 351-358, 2004.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Turk HF,
    2. Kolar SS,
    3. Fan YY,
    4. Cozby CA,
    5. Lupton JR,
    6. Chapkin RS
    : Linoleic acid and butyrate synergize to increase Bcl-2 levels in colonocytes. Int J Cancer 128: 63-71, 2011.
    OpenUrlCrossRefPubMed
    1. Hawkins RA,
    2. Sangster K,
    3. Arends MJ
    : Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J Pathol 185: 61-70, 1998.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Kolar SSN,
    2. Barhoumi R,
    3. Lupton JR,
    4. Chapkin RS
    : Docosahexaenoic acid and butyrate synergistically induce colonocyte apoptosis by enhancing mitochondrial Ca2 accumulation. Cancer Res 67: 5561-5568, 2007.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Fabiani R,
    2. Sepporta MV,
    3. Rosignoli P,
    4. De Bartolomeo A,
    5. Crescimanno M,
    6. Morozzi G
    : Antiproliferative and proapoptotic activities of hydroxytyrosol on different tumour cells: the role of extracellular production of hydrogen peroxide. Eur J Nutr 51: 455-464, 2012.
    OpenUrlPubMed
  25. ↵
    1. Visioli F,
    2. Galli C,
    3. Grande S,
    4. Colonnelli K,
    5. Patelli C,
    6. Galli G,
    7. Caruso D
    : Hydroxytyrosol excretion differes between rats and humans and depends on the vehicle of administration. J Nutr 133: 2612-2615, 2003.
    OpenUrlAbstract/FREE Full Text
    1. Vissers MN,
    2. Zock PL,
    3. Roodenburg AJ,
    4. Leenen R,
    5. Katan MB
    : Olive oil phenols are absorbed in humans. J Nutr 132(3): 409-417, 2002.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Tuck KL,
    2. Hayball PJ,
    3. Stupans L
    : Structural characterization of the metabolites of hydroxytyrosol, the principal phenolic component in olive oil in rats. J Agric Food Chem 50: 2404-2409, 2002.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 33, Issue 9
September 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Antitumorigenic Effect of Dietary Natural Compounds via Lipid Metabolism Modulation in ApcMin/+ Mice
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Antitumorigenic Effect of Dietary Natural Compounds via Lipid Metabolism Modulation in ApcMin/+ Mice
MARIA NOTARNICOLA, VALERIA TUTINO, ANGELA TAFARO, FRANCESCA AMATULLI, MARIA GABRIELLA CARUSO
Anticancer Research Sep 2013, 33 (9) 3739-3744;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Antitumorigenic Effect of Dietary Natural Compounds via Lipid Metabolism Modulation in ApcMin/+ Mice
MARIA NOTARNICOLA, VALERIA TUTINO, ANGELA TAFARO, FRANCESCA AMATULLI, MARIA GABRIELLA CARUSO
Anticancer Research Sep 2013, 33 (9) 3739-3744;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Cannabinoid Receptor-1 Up-regulation in Azoxymethane (AOM)-treated Mice After Dietary Treatment with Quercetin
  • Erythrocyte Membrane Fatty Acids Profile in Colorectal Cancer Patients: A Preliminary Study
  • Google Scholar

More in this TOC Section

  • POM121 Drives Gastric Cancer Progression via the mTOR/p70S6K Signaling Axis
  • Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine Dependence
  • mTOR Modulation Affects Galectin-1 Expression in KMT2A-rearranged Acute Lymphoblastic Leukemia Cells
Show more Experimental Studies

Keywords

  • olive oil
  • polyunsaturated fatty acids (PUFAs)
  • Colorectal cancer
  • lipid metabolism
  • gene expression
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire